Navigation Links
Cardiac Science Reports Strong Q1 Results
Date:4/30/2008

First quarter revenue up 17% to $49.0 million; EPS of $0.09

Defibrillation revenue up 27%; Cardiac monitoring revenue up 6%

Service revenue up 16%; Operating cash flow of $2.5 million

BOTHELL, Wash., April 30 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced strong results for the first quarter ended March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Revenue for the quarter was $49.0 million, an increase of 17% over the prior year period. This growth included increases in defibrillation sales of 27%, cardiac monitoring sales of 6% and service revenue of 16%.

Total international product sales grew 63% over the prior year's first quarter, driven by strong AED sales throughout Europe and Asia. Total domestic product sales remained constant, with domestic cardiac monitoring revenue up 6% over the prior year's first quarter, reflecting continuing growth after restructuring in 2007 to take advantage of all revenue opportunities in the market. The growth in domestic cardiac monitoring was offset by a slight decline in domestic AED sales, reflecting both the high comparable in the prior year and the inherent fluctuations that occasionally occur in that portion of the business. Service revenue was up 16%, reflecting both increased service billings and contracts in cardiac monitoring and increased AED related program management.

The Company reported net income of $2.1 million, or $0.09 per diluted share in the first quarter, compared to a net
'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Scientists identify novel way to prevent cardiac fibrosis
2. Cardiac Screening Recommended for Kids Taking Stimulants for ADHD
3. Health Leaders Join to Elevate Sudden Cardiac Arrest to a National Public Health Priority
4. CardiacAssist, Inc. Announces Five New TandemHeart Centers of Excellence
5. Cardiac Patients Admitted During Week More Likely to Survive
6. Extremely low dose CT coronary angiography shows promise in assessing cardiac function
7. Virginias largest Cardiac Surgery program adopts SPY as standard of care
8. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
9. U.S. Joins Case Against Cincinnati Health Care Facilities Alleging Kickbacks for Cardiac Services
10. Hands-Only Resuscitation OK for Cardiac Arrest
11. Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNewswire/...al leader in the development and delivery of custo...dical, scientific and academic markets, will be sh...rch, our first-to-market cross-platform search sol...lexicon, based on the American Psychological Assoc...
(Date:12/1/2009)... The Patient Safety Authority Encourages Older Per...ffers New Consumer Tips Based Upon Authority Data ...wire/ -- Ninety percent of all vaccine preventable...idents in nursing homes, according to highlighted ...ty,s 2009 December Patient Safety Advisory . ,...
(Date:12/1/2009)... who believe that happiness declines with age are ...ch as binge drinking. Their misguided negative vie...o behave ,sensibly, and encourage them to make the..., old age. These findings 1 by Dr. John Garry an... Northern Ireland, are published online in Springe...
(Date:12/1/2009)...rdiovascular system tied to academic achievement, ...y News) -- A strong cardiovascular system in young... school grades and more overall success later in l...octors and laypeople know (or should know) the ben..., the authors of a new study, appearing in this we...
(Date:12/1/2009)... , RANCHO SANTA FE, Calif., Dec. 1 /PRNewswire/..., the ingredient in grapes acclaimed for its poten... hit the marketplace. ,, (Photo: http://www.ne...Logo: http://www.newscom.com/cgi-bin/prnh/2009111...) Bar, developed by ResVez, Inc. of Rancho Santa F...
Breaking Medicine News(10 mins):Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Binge drinking youths find getting old a drag 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:First Resveratrol Nutrition Bar Hits the Market 2
...ndocrinologist and nationally renowned obesity exp..., says that the obesity epidemic// is caused by a ...iochemistry and driving them to eat more and move ...m thousands of studies on obesity. He says that it...
...t issue of the journal Neuron, published by Cell P...r, Ivan de Araujo and colleagues,// have mapped th...hunger-satiety-hunger cycle in multiple feeding-re... at specific times in the feeding cycle, but the f...
...h is the country's only tuberculosis hospital that...services from Thursday.// The 37-bed hospita...ts services from Thursday the 17th of August, with...g the congregation at the programme organised to m...
...t Thailand’s Public Health Ministry will encourage...help screen patients in an attempt// to prevent th...Minister Pinij Charusombat said, the blue-collar w...ospitals and other health care facilities screen t...
...bducted by Taliban at gunpoint were freed shortly ... that they were all health workers. // They abduct.... The militants snatched on Thursday a vehicl...al, deputy director of the provincial health burea...
...o Ghosh’s film “Sunglass” was unfortunately bought...s Konkona Sen Sharma’s right eye swelling// up for...pparently make up could not conceal the swollen ar... is my first bi-lingual. And I've never had so muc...
Other Medicine News:Health News:Processed foods – "the" cause of obesity! 2Health News:Processed foods – "the" cause of obesity! 3Health News:Processed foods – "the" cause of obesity! 4Health News:Hunger Mapping 2Health News:A sty in Actress Konkona Sharma Disrupts the Shooting of Bi- Lingual movie 'Sunglass' 2
(Date:12/1/2009)...ATAWAY, N.J., Dec. 1 Siemens Hear...ng) a leading global manufacturer of hearing instr...h Quota International,s Sound Beginnings program. ...010. ,, As part of the renewed partnership, Sie...for 100 free hearing instruments to both children ...
(Date:12/1/2009)...GO, Dec. 1 ADVENTRX Phar...ed that a new, recently completed preclinical stud...oxicity of ANX-514 and Taxotere® (docetaxel)....or ANX-514 in South Korea, independently conducted...dent confirmation of the bioequivalence and compar...
(Date:12/1/2009)...LE, Md., Dec. 1 Vanda Ph...y that the waiting period has expired under the Ha...f 1976 with respect to Vanda,s agreement, dated Oc...the agreement is now effective. Expiration of the...f the agreement, triggers an upfront payment to Va...
Breaking Medicine Technology:Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 1Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 2Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 3Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 4Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 5Boston Scientifics Urology Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 48889 6HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research 48886 1HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research 48886 2HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research 48886 3HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research 48886 4Cynvec to Present at The 2009 New York Venture Summit 12624 1Cynvec to Present at The 2009 New York Venture Summit 12624 2
...Patient Cohort Enrolled in Stage A of Trial Assess...Carboplatin and Paclitaxel -, TUSTIN, Calif., Oct...M ), a clinical stage biopharmaceutical,company de...f cancer and,hepatitis C virus (HCV) infection, to...the first stage of a Phase II trial of bavituximab...
...PPENHAM, England, October 7 ,Sosei Group Corporati...Group plc ("Vectura"; LSE: VEC), announce results ...afety and tolerability of NVA237 presented at the,...y (ERS) in Berlin,Germany. The new data show that ...ong-acting muscarinic antagonist (LAMA), provides ...
Other Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: